Skip to main content
. 2020 Jun 9;7:315. doi: 10.3389/fmed.2020.00315

Table 2.

Comparisons of laboratory indices, radiographic findings, and treatments of 125 patients with COVID-19 between the two groups.

Characteristics Total (n = 125) Short-term group (n = 66) Long-term group (n = 59) Z2 P
WBC (×109/L) 5.90 (4.54–7.43) 5.87 (4.49–7.42) 5.90 (4.56–7.58) −0.040 0.968
  <3.5 13 (10.40) 6 (9.09) 7 (11.86) 2.467 0.291
 3.5–9.5 100 (80.00) 56 (84.84) 44 (74.58)
 >9.5 12 (9.60) 4 (6.07) 8 (13.56)
Lymphocyte count (×109/L) 1.31 (0.87–1.82) 1.59 (1.07–2.09) 1.18 (0.76–1.58) −3.326 0.001*
  <1.1 43 (34.40) 18 (27.27) 25 (42.37) 4.540 0.103
 1.1–3.2 81 (64.80) 48 (72.73) 33 (55.93)
 >3.2 1 (0.80) 0 (0) 1 (0.80)
Hemoglobin (g/L) 130.0 (118.0–140.0) 133.0 (120.0–144.0) 128.0 (116.0–137.0) −1.234 0.217
 Anemia 61 (48.80) 29 (43.94) 32 (54.24) 1.322 0.250
PLT (×109/L) 210.0 (170.0–257.0) 223.5 (187.75–270.75) 196.0 (160.0–243.0) −2.396 0.017*
  <125 6 (4.80) 1 (1.52) 5 (8.47) 3.321 0.190
 125–350 103 (82.40) 56 (84.85) 47 (79.66)
 >350 16 (12.80) 9 (13.63) 7 (11.87)
CRP (mg/L) 6.70 (1.30–41.8) 2.20 (0.68–12.82) 17.40 (2.80–66.50) −4.044 0.000*
  <1 27 (21.60) 20 (30.30) 7 (11.86) 18.931 0.001*
 1–3 24 (19.20) 16 (24.24) 8 (13.56)
 3–10 17 (13.60) 11 (16.67) 6 (10.17)
 10.1–50 30 (24.00) 13 (19.70) 17 (28.81)
 >50 27 (21.60) 6 (9.10) 21 (35.59)
Troponin I (pg/mL) 3.9 (1.9–10.3) 1.90 (1.90–7.52) 6.90 (1.90–12.50) −3.043 0.002*
  ≤ 34.2 115 (92.00) 63 (95.45) 52 (88.14) 2.267 0.189
 >34.2 10 (8.00) 3 (4.55) 7 (11.86)
BNP (pg/mL) 65.0 (23.0–178.0) 52.0 (19.75–178.0) 96.0 (29.0–209.0) −1.328 0.184
  <486 107 (85.60) 58 (87.88) 49 (83.05) 0.589 0.443
 ≥486 18 (14.40) 8 (12.12) 10 (16.95)
Myoglobin (ng/mL) 35.0 (27.7–75.65) 32.70 (24.52–53.18) 40.30 (29.0–102.5) −2.087 0.037*
  ≤ 154.9 111 (88.80) 61 (92.42) 50 (84.75) 1.874 0.174
 >154.9 14 (11.20) 5 (7.58) 9 (15.25)
CKMB (ng/mL) 0.7 (0.5–1.2) 0.70 (0.5–1.2) 0.8 (0.5–1.2) −0.583 0.560
Albumin (g/L) 40.0 (33.75–43.15) 41.3 (36.1–44.43) 37.4 (31.9–41.9) −3.375 0.001*
 35–52 85 (68.00) 42 (78.79) 33 (55.93) 7.479 0.006*
  <35 40 (32.00) 14 (21.21) 26 (44.07)
ALT (U/L) 24.0 (14.0–36.5) 20.50 (12.50–34.50) 25.0 (18.0–38.0) −1.363 0.173
  ≤ 41 103 (82.40) 55 (83.33) 48 (81.36) 0.084 0.772
 >41 22 (17.60) 11 (16.67) 11 (18.64)
AST (U/L) 22.0 (16.0–32.5) 19.00 (14.0–26.25) 26.0 (18.0–36.0) −2.797 0.005*
  ≤ 40 107 (85.60) 58 (87.88) 49 (83.05) 0.589 0.443
 >40 18 (14.40) 8 (12.12) 10 (16.95)
Urea (mmol/l) 4.5 (3.4–5.5) 4.40 (3.2–5.33) 4.6 (3.6–5.9) −1.437 0.15
 3.6–9.5 119 (95.20) 63 (95.45) 56 (94.92) 0.000 1.000
 >9.5 6 (4.80) 3 (4.55) 3 (5.08)
Creatinine (μmol /l) 69.0 (57.0–87.0) 68.0 (55.75–88.25) 69.0 (60.0–88.0) −0.646 0.519
 59–104 114 (91.20) 61 (92.42) 53 (89.83) 0.261 0.609
 >104 11 (8.80) 5 (7.58) 6 (10.17)
LDH (U/L) 200 (165.5–269.5) 182.5 (153.75–232.75) 239.0 (190.0–303.0) −3.793 0.000*
 135–225 74 (59.20) 48 (72.73) 26 (44.07) 10.594 0.001*
 >225 51 (40.80) 18 (27.27) 33 (55.93)
Potassium (mmol/l) 4.06 (3.76–4.32) 4.07 (3.74–4.25) 4.04 (3.77–4.37) −0.361 0.718
 3.5–5.1 110 (88.00) 60 (90.91) 50 (84.75) 1.447 0.668
  <3.5 13 (10.40) 5 (7.58) 8 (13.56)
 >5.1 2 (1.60) 1 (1.51) 1 (1.69)
Sodium (mmol/l) 139.4 (136.9–140.7) 139.5 (137.8–140.75) 139.0 (134.8–140.7) −1.521 0.121
 136–145 102 (81.60) 59 (89.40) 43 (72.88) 7.667 0.021*
  <136 22 (17.60) 6 (9.09) 16 (27.12)
 >145 1 (0.80) 1 (1.51) 0
Chlorine (mmol/l) 101.1 (98.35–103.0) 101.85 (99.6–102.92) 100.0 (97.0–103.3) −1.551 0.121
 99–110 87 (69.60) 52 (78.79) 35 (59.32) 5.579 0.019*
  <99 38 (30.40) 14 (21.21) 24 (40.68)
Calcium (mmol/l) 2.16 (2.08–2.23) 2.19 (2.13–2.25) 2.12 (2.03–2.18) −3.541 0.000*
 2.2–2.5 44 (35.20) 32 (48.48) 12 (20.34) 10.819 0.001*
  <2.20 81 (64.80) 34 (51.52) 47 (79.66)
PT (sec) 13.60 (13.05–14.10) 13.5 (12.97–13.90) 13.8 (13.2–14.3) −2.176 0.030*
 11.5–14.5 112 (89.60) 63 (95.45) 49 (83.05) 5.143 0.023*
 >14.5 13 (10.40) 3 (4.55) 10 (16.95)
APTT (sec) 37.8 (35.7–40.9) 37.7 (35.6–40.9) 37.9 (36.3–41.6) −0.480 0.631
 29.0–42.0 102 (81.60) 57 (86.36) 45 (76.27) 2.113 0.146
 >42.0 23 (18.40) 9 (13.64) 14 (23.73)
TT (sec) 16.6 (15.85–17.2) 16.5 (15.8–17.12) 16.7 (16.0–17.6) −1.205 0.228
 14.0–19.0 119 (95.20) 64 (96.97) 55 (93.22) 0.958 0.420
 >19.0 6 (4.80) 2 (3.03) 4 (6.78)
Fibrinogen (g/L) 3.84 (2.98–5.1) 3.37 (2.73–4.49) 4.69 (3.22–5.78) −3.665 0.000*
 2–4 90 (72.00) 56 (84.85) 34 (57.63) 11.450 0.001*
 >4 35 (28.00) 10 (15.15) 25 (42.37)
D-dimer (ug/mL) 0.37 (0.22–0.83) 0.22 (0.22–0.78) 0.50 (0.26–1.01) −2.760 0.006*
  <0.5 75 (60.00) 45 (68.18) 30 (50.85) 3.900 0.048*
 ≥0.5 50 (40.00) 21 (31.82) 29 (49.15)
Chest CT findings
 No pneumonia 11 (8.80) 9 (13.64) 2 (3.39) 16.845 0.00*
 Unilateral pneumonia 53 (42.40) 36 (54.55) 17 (28.81)
 Bilateral pneumonia 61 (48.80) 21 (31.81) 40 (67.80)
Treatment
 Antibiotics 80 (64.00) 33 (50.00) 47 (79.66) 11.895 0.001*
 Antiviral 118 (94.40) 60 (90.90) 58 (98.31) 3.223 0.073
 Oxygen therapy 72 (57.60) 36 (54.55) 36 (61.02) 3.206 0.201

Data are shown as median (interquartile range) or n (%). P-values were calculated by Mann-Whitney U test, χ2 test or Fisher's exact test, as appropriate. WBC, White blood cell; PLT, platelet count; CRP, C-reactive protein; BNP, B-type natriuretic peptide; CKMB, creatine kinase isoenzyme; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactic dehydrogenase; PT, prothrombin time; ATPP, activated partial thromboplastin time; TT, thrombin time; CT, computed tomographic;

*

P < 0.05 denoted siginificant difference between patients with short-term and long-term hospitalization.